What is the price target for MX4A stock?
20 analysts have analysed MX4A.DE and the average price target is 272.08 EUR. This implies a price increase of 12.76% is expected in the next year compared to the current price of 241.3.
FRA:MX4A • US12572Q1058
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CME GROUP INC (MX4A.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-07-01 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-06-14 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-06-11 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-06-10 | Atlantic Equities | Downgrade | Overweight -> Neutral |
| 2021-04-30 | Argus Research | Downgrade | Buy -> Hold |
| 2021-04-29 | Citigroup | Maintains | Buy |
| 2021-04-20 | Citigroup | Maintains | Buy |
| 2021-03-24 | B of A Securities | Upgrade | Neutral -> Buy |
| 2021-02-25 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2021-02-11 | Citigroup | Maintains | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.854B 50.38% | 10.209B -5.94% | 11.951B 17.06% | 7.163B -40.06% | 7.478B 4.40% | 7.955B 6.38% | 8.181B 2.84% | 8.568B 4.73% | |
| EBITDA YoY % growth | 9.064B 62.52% | 8.347B -7.90% | 9.991B 19.69% | 5.143B -48.52% | 5.312B 3.29% | 5.835B 9.85% | 6.407B 9.80% | 6.723B 4.93% | |
| EBIT YoY % growth | 8.711B 67.06% | 8.011B -8.04% | 9.66B 20.59% | 4.899B -49.29% | 5.139B 4.90% | 5.49B 6.83% | 5.968B 8.71% | 6.247B 4.67% | |
| Operating Margin | 80.25% | 78.46% | 80.83% | 68.39% | 68.72% | 69.01% | 72.95% | 72.91% | |
| EPS YoY % growth | 9.34 17.04% | 10.26 9.85% | 11.21 9.26% | 12.28 9.56% | 12.93 5.25% | 13.93 7.77% | 15.13 8.63% | 14.70 -2.89% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 3.14 6.19% | 2.99 11.58% | 2.99 7.86% | 3.35 -0.29% | 3.31 5.42% | 3.18 6.19% | 3.18 6.29% | 3.60 7.32% | 3.56 7.28% | 3.49 10.05% | 3.33 4.96% |
| Revenue Q2Q % growth | 1.79B 5.79% | 1.719B 11.80% | 1.754B 6.39% | 1.918B 2.02% | 1.897B 5.98% | 1.784B 3.78% | 1.85B 5.47% | 2.022B 5.42% | 2B 5.43% | 1.968B 10.31% | 1.929B 4.27% |
| EBITDA Q2Q % growth | 1.301B -53.76% | 1.235B -55.41% | 1.214B -56.97% | 1.383B -3.49% | 1.36B 4.53% | 1.295B 4.86% | 1.278B 5.27% | 1.487B 7.52% | 1.459B 7.28% | 1.421B 9.73% | 1.356B 6.10% |
| EBIT Q2Q % growth | 1.264B -52.26% | 1.197B -52.52% | 1.193B -52.09% | 1.391B -48.46% | 1.353B 7.04% | 1.25B 4.43% | 1.26B 5.62% | 1.459B 4.89% | 1.432B 5.84% | 1.393B 11.44% | 1.328B 5.40% |
All data in USD
20 analysts have analysed MX4A.DE and the average price target is 272.08 EUR. This implies a price increase of 12.76% is expected in the next year compared to the current price of 241.3.
CME GROUP INC (MX4A.DE) will report earnings on 2026-07-21, before the market open.
The consensus EPS estimate for the next earnings of CME GROUP INC (MX4A.DE) is 3.14 EUR and the consensus revenue estimate is 1.79B EUR.
The number of analysts covering CME GROUP INC (MX4A.DE) is 20.